Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis

Overview of attention for article published in Breast Cancer Research, June 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 76 Mendeley

So far, Altmetric has seen 1 X post from an account with 961 followers.

IL-6 and CCL5 pathways promote crosstalk between #TNBC and #lymphatic vessels and enhance of TNBC’s tumor growth and #metastasis. Promising #preclinical results of the maraviroc (#CCR5 inhibitor) plus tocilizumab (anti-IL-6 receptor #antibody) combo #MBC h

26 Jun 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.